ARA-290 10MG
🔥 Peptide of the Week
🎁 Exclusive VIP discounts
📦 Early access to launches and restocks
👥 Members-only giveaways
⭐ 100+ members already inside!
Only 19 spaces left until our 50-member giveaway!
📲 Message us via the Contact form to join the WhatsApp group.
ARA-290 10MG Vial — Premium Research-Grade Tissue Protection Peptide
A precisely formulated single vial of ARA-290 10MG, developed for researchers investigating compounds associated with tissue protection, inflammation, nerve regeneration, and cellular repair. Each vial is manufactured to exacting research-grade standards, ensuring exceptional consistency, purity, and reliability across every batch.
ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO) that has attracted significant scientific interest due to its potential tissue-protective properties without exhibiting the erythropoietic effects associated with full-length EPO. Its unique mechanism has made it an important compound within regenerative medicine and inflammation research.
For larger research requirements, ARA-290 10MG is also available in convenient multi-vial bundles of 10 directly from the product selection menu.
Vial Specifications
• 10MG per vial — suitable for a range of structured laboratory research protocols
• High-purity formulation — manufactured under rigorous quality controls
• Securely sealed and packaged to preserve integrity during storage and transit
• Suitable for in vitro and laboratory research applications
Research Context
ARA-290 is an 11-amino acid peptide designed to selectively activate the innate repair receptor (IRR), a receptor complex involved in tissue protection and repair. Researchers continue to investigate its potential role in reducing inflammatory signalling, promoting nerve regeneration, supporting tissue recovery, and protecting cells from injury.
Scientific investigations have explored ARA-290 across multiple research areas, including neuropathic pain models, peripheral nerve regeneration, metabolic health, cardiovascular biology, kidney protection, and inflammatory diseases. Its selective mechanism of action has made it a particularly promising research compound for studying tissue repair without stimulating red blood cell production.
Due to its broad relevance across regenerative science and immunology, ARA-290 has become an increasingly important peptide within laboratory research.
Why Researchers Are Interested in ARA-290
• Extensive interest within tissue protection and regenerative medicine research
• Ongoing investigations into inflammation and immune signalling
• Research exploring peripheral nerve regeneration and neuropathic pain models
• Scientific interest relating to cardiovascular, renal, and metabolic health
• Selective activation of the innate repair receptor without erythropoietic activity
Related Research Compounds
Researchers exploring ARA-290 may also be interested in:
• BPC-157
• TB-500
• Thymosin Alpha-1
• KPV
• GHK-CU
While these compounds differ in their mechanisms of interest, they share overlapping areas of scientific investigation relating to tissue regeneration, inflammation research, cellular repair, and recovery biology.
For Research Purposes Only. This product is strictly intended for laboratory and in vitro research use only. It is not intended for human administration, clinical use, diagnosis, treatment, prevention of disease, or resale for investigational purposes.
Each product is professionally third-party tested, with Certificates of Analysis (COAs) available for quality assurance and research verification.
Precision. Purity. Consistency.